Walgreens Recalls Thiamine Vials Due to Sterility Assurance Concerns
Walgreens Infusion Services is recalling Thiamine 100 mg/ml vials due to a lack of sterility assurance. The products were distributed in six states.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II. According to the rubric, an FDA Class II recall involving a significant risk such as lack of sterility assurance in an injectable product corresponds to a Severe rating (Score 4), as it carries a risk of serious injury or hospitalization.
Plain-English summary
Walgreens Infusion Services is recalling Thiamine 100 mg/ml vials because of a lack of sterility assurance. The recall covers all products within their expiration dates.
The affected products were distributed in Texas, Florida, Virginia, Georgia, Louisiana, and Mississippi. The source text does not specify the exact number of units recalled or report any specific illnesses or injuries associated with the product.
Consumers and healthcare providers should stop using the recalled vials and contact their supplier or Walgreens Infusion Services for further instructions on disposal or replacement.
The recalled product
- Product
- Thiamine 100 mg/ ml vials
- Manufacturer
- Walgreens Infusion Services
- Category
- Drug — Injectable Medication
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All products within expiry.
Distribution
Part of a larger recall action
This product is one of 36 recalled by Walgreens Infusion Services under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 36 products in this recall →Related recalls
Same manufacturer · Walgreens Infusion Services
See all →- SevereWalgreens Recalls IVIG Gamunex Bags Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- SevereWalgreens Recalls Cefazolin Infusion Bags Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- SevereWalgreens Recalls 0.9% Sodium Chloride/MVI Injection Bags Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- SevereWalgreens Infusion Services Recalls Dextrose and Sodium Chloride Injection Bags
FDA (Drugs) · 2016-01-06
- HighWalgreens Recalls Famotidine Injection Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- SevereWalgreens Recalls Thiamine Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- SevereMedaus Recalls Thiamine Vials Due to Lack of Sterility Assurance
FDA (Drugs) · 2016-07-20
- SevereMedaus Recalls Thiamine Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2016-07-20
- SevereGentamicin Syringes Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2016-01-06
- HighWalgreens Recalls Insulin Syringes Due to Sterility Assurance Concerns
FDA (Drugs) · 2016-01-06
- HighWalgreens Recalls L-Cysteine Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-01-06